Carol Gallagher, Pharm.D.
Board Member
Atara Biotherapeutics, Inc. (ATRA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carol Gallagher, Pharm.D.
Carol Gallagher, Pharm.D. is recorded as Board Member at Atara Biotherapeutics, Inc. (ATRA). Atara Biotherapeutics, Inc. reported in an 8-K filed August 12, 2024 that Carol Gallagher, Pharm.D. was appointed Independent Lead Director, effective September 9, 2024. Atara Biotherapeutics, Inc. reported in an 8-K filed June 5, 2023 that Carol Gallagher, Pharm.D. was appointed Director, effective May 31, 2023.
“Carol Gallagher, Pharm.D., current Chair of the Board, will transition to become Independent Lead Director”
“Each of the three nominees for director was elected to serve until the 2026 annual meeting of stockholders and until their respective successors are elected.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atara Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- AnhCo "Cokey" Thieu Nguyen CEO
- AnhCo Nguyen CEO, Board Member
- Cokey Nguyen CEO
- Cokey Nguyen, Ph.D. CEO, Board Member
- Isaac Ciechanover M.D CEO
- Carol D. Gallagher, Pharm D. Chairman
- Gregory A. Ciongoli Chairman, Board Member
- Pascal Touchon Chairman
- Ron Renaud Chairman, Board Member
- Eric Hyllengren CFO, COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.